| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 10/04/2005 | US6951872 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors |
| 10/04/2005 | US6951850 Dipeptide derivatives |
| 09/29/2005 | WO2005090564A1 Gene promoting vascular endothelial cell growth |
| 09/29/2005 | WO2005089743A1 Therapeutic agent for renal anemia |
| 09/29/2005 | WO2005089739A1 Medical emulsion of perfluororganic compounds and method for the production thereof |
| 09/29/2005 | WO2005089714A1 Emulsion stabilizer |
| 09/29/2005 | WO2005063801A3 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 09/29/2005 | US20050215626 Substituted benzofuran oximes; inhibiting PAI-1 activity; Plasminogen Activator Inhibitor (PAI); treating thrombosis, pulmonary fibrosis, stroke, myocardial ischemia, cardiovascular disease, chronic obstructive pulmonary disease, diabetes, Alzheimer's disease, renal fibrosis, or cancer |
| 09/29/2005 | US20050215625 Combination therapy for anticoagulation |
| 09/29/2005 | US20050215593 Kaposi's sarcoma; Crohn's disease |
| 09/29/2005 | US20050215550 Pyrazole-derived kinase inhibitors and uses thereof |
| 09/29/2005 | US20050215547 Optically active pyridine derivative and a medicament containing the same |
| 09/29/2005 | US20050215518 Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation |
| 09/29/2005 | US20050215502 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/29/2005 | US20050214762 Receptor binding domains of leptin; proteolysis; fusion proteins |
| 09/29/2005 | US20050214291 Treatment method |
| 09/29/2005 | US20050214262 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine |
| 09/29/2005 | DE10393402T5 Mittel und Toilettenartikel- oder pharmazeutische Zusammensetzung zum Beschleunigen der Aufnahme von basischen Aminosäuren in Zellen Means and Toilettenartikel- or pharmaceutical composition to accelerate the uptake of basic amino acids in cells |
| 09/29/2005 | CA2562388A1 Emulsion-stabilized preparation |
| 09/29/2005 | CA2560247A1 Thrombin derivative and pharmaceutical composition containing the same |
| 09/29/2005 | CA2557833A1 Emulsion of fluorocarbon compounds for medical purposes and method for production thereof |
| 09/29/2005 | CA2555036A1 Antithrombotic compound |
| 09/28/2005 | EP1579871A1 Vascular endothelial cell growth factor antagonists and uses thereof |
| 09/28/2005 | EP1578914A2 Human ion channels |
| 09/28/2005 | EP1578897A2 Process for inducing functional tolerance to gene transfer products |
| 09/28/2005 | EP1578771A2 Remodeling and glycoconjugation of peptides |
| 09/28/2005 | EP1578423A1 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
| 09/28/2005 | EP1578347A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 09/28/2005 | EP1439846A4 Storage-stable human fibrinogen solutions |
| 09/28/2005 | EP1397348B1 Factor xa inhibitor |
| 09/28/2005 | EP1366029B1 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolins and the utilization thereof as anticoagulant and antithrombotic agents |
| 09/28/2005 | EP1307430B1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 09/28/2005 | EP1289559B8 Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 09/28/2005 | EP1228072B1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 09/28/2005 | EP1086099B1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 09/28/2005 | EP0963200B1 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid |
| 09/28/2005 | CN1675250A Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation |
| 09/28/2005 | CN1675249A Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 09/28/2005 | CN1675248A Highly branched, unsubstituted or low-substituted starch products, dialysis solution and plasma expander containing the same, and the use thereof |
| 09/28/2005 | CN1675229A Sulfur-containing phospholipid derivatives |
| 09/28/2005 | CN1675210A Substituted 2, 4-dihydro-pyrrolo[3, 4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors |
| 09/28/2005 | CN1675201A N-substituted piperidine derivatives as serotonin receptor agents |
| 09/28/2005 | CN1675198A Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders |
| 09/28/2005 | CN1675193A Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(n-2-pyridyl-n-2-hydroxycarbonylethyl)-amide |
| 09/28/2005 | CN1675185A Therapeutic molecules and methods-1 |
| 09/28/2005 | CN1675184A Caspase inhibitors and uses thereof |
| 09/28/2005 | CN1674942A Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 09/28/2005 | CN1674928A Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
| 09/28/2005 | CN1674921A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 09/28/2005 | CN1674895A Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/28/2005 | CN1674894A Ether substituted imidazopyridines |
| 09/28/2005 | CN1673363A Pallas pit viper active hepatoenzyme |
| 09/28/2005 | CN1672705A Dispersive tablet of nudiflorus Taiwan beautyberry leaf and its prepn |
| 09/28/2005 | CN1672692A Naoxuekang dripping pill and its prepn process |
| 09/28/2005 | CN1220683C Acyl derivatives for treating VLA-4 related disorders |
| 09/28/2005 | CN1220682C Heterocycle derivatives inhibiting factor Xa |
| 09/28/2005 | CN1220681C Indole derivatives as XA factor inhibitors |
| 09/28/2005 | CN1220513C Chinese patent medicine for stopping blood, analgesia, removing blood stasis and engender new and its preparation method |
| 09/28/2005 | CN1220510C Chinese patent medicine with the functions of replenishing qi and blood and nourishing the heart to calm the mind, its preparation method and quality control method |
| 09/28/2005 | CN1220509C Chinese patent medicine for curing cardiovascular disease, its preparation method and quality control method |
| 09/28/2005 | CN1220488C Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction |
| 09/27/2005 | US6949646 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases |
| 09/27/2005 | US6949580 Anticancer agents; restenosis; antiinflammatory agents; cardiovascular disorders |
| 09/27/2005 | US6949575 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives |
| 09/27/2005 | US6949565 Protein kinase inhibitors |
| 09/27/2005 | US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 09/27/2005 | US6949555 Use of organic compounds |
| 09/27/2005 | US6949550 Substituted amino methyl factor Xa inhibitors |
| 09/27/2005 | US6949544 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 09/27/2005 | US6949535 for example, 2-(6-aminopurin-9-ylmethyl)-3-(2-chlorophenyl)-6,7-dimethoxy-3H-quinazolin-4-one |
| 09/27/2005 | US6949509 Pharmaceutical composition containing a small or medium size peptide |
| 09/27/2005 | CA2255539C Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma |
| 09/27/2005 | CA2121997C 3-deoxy oligosaccharides, processes for preparing them and pharmaceutical compositions containing them |
| 09/27/2005 | CA2108104C Fibrin sealant compositions and methods for utilizing same |
| 09/22/2005 | WO2003065997A3 Anti-infarction molecules |
| 09/22/2005 | WO2000075279A3 Nucleotide sequences for gene regulation and methods of use thereof |
| 09/22/2005 | US20050209462 Synthesis of benzimidate from benzoic acid |
| 09/22/2005 | US20050209326 Therapeutic uses for nitric oxide inhibitors |
| 09/22/2005 | US20050209286 RXR activating molecules |
| 09/22/2005 | US20050209267 Thioether substituted imidazoquinolines |
| 09/22/2005 | US20050209261 Rho-kinase inhibitors |
| 09/22/2005 | US20050209244 N{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 09/22/2005 | US20050209240 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors |
| 09/22/2005 | US20050209234 4-Oxo-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds |
| 09/22/2005 | US20050209225 Substituted indoles and their use as integrin antagonists |
| 09/22/2005 | US20050209192 Autoimmune disorders; modulating protein kinase C activity |
| 09/22/2005 | US20050209175 Idraparinux(sanorg34006)for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis |
| 09/22/2005 | US20050209154 Containing high-molecular vWF multimers and being free from low-molecular vWF molecules and proteolytic vWF degradation products; chromatographic purification of Factor VIII or a Factor VIII/vWF-complex, admixing a purified high-molecular fraction of vWF molecules; hemophilia A, von Willebrand Disease |
| 09/22/2005 | US20050208655 Blood cells having modified antigenicity |
| 09/22/2005 | US20050208610 Method of producing an anticoagulation effect |
| 09/22/2005 | US20050208536 Comprises ribonuclease barnase marker gene; libraries; drug resistance |
| 09/22/2005 | US20050208525 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response |
| 09/22/2005 | US20050208154 Antidepressants for treating manic disorders, psychosis; comprising ethyl cellulose, talc, polyvinylpyrrolidone; time-release dosage form; once daily |
| 09/22/2005 | US20050208137 comprising angiogenesis inhibitor retinoic acid, taxol and polymeric carrier polylactone; treating cancer, angiogenic-dependent diseases, embolizing blood vessels, and eliminating biliary, urethral, esophageal, tracheal/bronchial obstructions, corneal neovascularization; coated stents with the mixture |
| 09/22/2005 | US20050208135 Monocompartment osmotic controlled drug delivery system |
| 09/22/2005 | US20050208128 Immediate release tablet |
| 09/22/2005 | US20050208081 With water miscible solubilizer; phosphodiesterase inhibitors; cardiovascular disorders |
| 09/22/2005 | US20050208042 Inducing lack of responsiveness to an antigen in an individual having a transplanted organ, tissue, cell; administering an effective amount of a humanized antibody; one antigen binding region of nonhuman origin and a portion of an immunoglobulin heavy chain of human origin |
| 09/21/2005 | EP1577323A1 Metastin derivative and use thereof |
| 09/21/2005 | EP1577317A1 Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof |